Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
KNSA

Market Cap: $5.81B

KP

Kiniksa Pharmaceuticals International, plc

KNSA

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin54.49%

EBITDA Margin13.33%

EBIT Margin13.12%

Pre-tax Margin13.59%

Net Profit Margin9.59%

Earnings Yield1.36%

Valuation Multiples

Price / Book9.05

Price / Sales6.91

Price / Earnings71.28

PEG0.04

Forward PEG1.51

EV / Sales6.71

EV / EBITDA50.36

EV / Operating Cash Flow30.48

EV / Free Cash Flow30.83

Price / Free Cash Flow31.74

Price / Operating Cash Flow31.94

Cash Flow & Capital

Free Cash Flow / Share$2.36

Operating Cash Flow / Share$2.39

Free Cash Flow Yield3.15%

Capex / Revenue0.25%

Capex / Operating Cash Flow1.15%

Capex / Depreciation0.70

Stock Compensation / Revenue4.25%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio3.90

Quick Ratio3.49

Cash Ratio1.03

Debt / Assets0.01

Debt / Capital0.01

Debt / Equity0.01

Long-Term Debt / Capital0.00

Debt / Market Cap0.00%

Net Debt / EBITDA-1.49

Solvency Ratio0.34

Financial Leverage1.37

Efficiency & Working Capital

Asset Turnover0.94

Fixed Asset Turnover76.94

Inventory Turnover5.40

Receivables Turnover35.80

Payables Turnover30.85

Days Sales Outstanding10.2

Days Inventory Outstanding67.65

Days Payables Outstanding11.83

Operating Cycle77.85

Cash Conversion Cycle66.02

Working Capital Turnover1.80

Returns & Quality

Return on Equity13.65%

Return on Assets9.00%

Return on Invested Capital9.71%

ROCE13.83%

Return on Tangible Assets9.15%

Operating Return on Assets11.65%

Income Quality-8.60

Tax Burden0.71

Interest Burden1.04

Balance Sheet & Intrinsic Metrics

Enterprise Value$5.65B

Invested Capital$523.06M

Working Capital$497.39M

Tangible Asset Value$639.4M

Net Current Asset Value$426.67M

Graham Number$14.04

Graham Net-Net$4.34

Book Value / Share$8.43

Tangible Book Value / Share$8.24

Cash / Share$6.78

Financial Health Scores

Piotroski Score6

Altman Z-Score15.83

Revenue$840.85M

EBIT$110.3M

Market Cap$5.84B

Working Capital$497.39M

Retained Earnings$-414.11M

Total Assets$896.11M

Total Liabilities$241.96M